Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaReduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionThe tumor microenvironment in esophageal cancerCombination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I studyRole of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experienceEffect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagusNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.Expression of cyclooxygenase (COX)-2 as a prognostic factor in nasopharyngeal cancer.Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysisChemoprevention of esophageal adenocarcinomaBarrett's esophagus and the increasing role of endoluminal therapy.Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implicationsThe HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancerL-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.American Gastroenterological Association technical review on the management of Barrett's esophagusAdenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Barrett's Esophagus: Emerging Knowledge and Management StrategiesBarrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line.Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell linesThyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of AgeThe SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression.Proliferative activity of bile from congenital choledochal cyst patientsLocal Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003.NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.Esophageal adenocarcinoma arising in Barrett esophagusRole of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.New models of neoplastic progression in Barrett's oesophagus.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.
P2860
Q21563424-9B52579B-9615-4352-B845-F4272551715EQ24550932-377E52C4-DC13-4D54-BAAA-3A46286FB9E4Q27026253-65D7C6F7-F978-48E4-8762-6FAC6F87B3AEQ28077074-073D5884-553A-4E9C-80DE-5C582A724D97Q28218423-E4BD69B3-91DD-487A-AA84-C9F5F1164B5CQ28303196-8280BC31-7005-4854-B9DF-747A253E0DC1Q31066911-E08CBACC-D32F-46D9-A005-A581030D1FE6Q33244119-0538DD18-865B-4E0A-8A3B-EB4E28A4A61DQ33664095-FB4E1CFD-2856-4E53-B148-CE5E8FBAC1E4Q33754989-542548B0-C9C5-40F3-8249-F9534978686DQ33791341-07CCF7A1-02F7-4700-9615-D052ADD9984CQ33799761-786EC1BE-DED4-4DCF-BD07-66EBA9DD352FQ34100102-CA6A89E8-9735-4323-869E-6579400AECE6Q34333203-21ABDA41-E2AA-46CD-B644-DD2621B52D90Q34408890-613E2153-4FB0-4620-A6F6-C4F71B1FDF84Q34408906-FA830891-3FC9-49EA-A540-36912CA22ADCQ34567287-66E97BB3-11DB-4105-9513-8C7F69AE2F75Q34724977-8AC12D19-CBCF-444F-BB38-79CABAF00C95Q34733346-696C486D-7CC7-47C1-8E2B-44FAC1BAD1CFQ34787881-95855B83-0311-4AED-A957-84F174689EA3Q35116562-49F52A04-00B6-4AAC-9CD3-5A7B3FBCB2C0Q35549847-854280EC-403D-46D8-A02F-735F8FDC707EQ35673305-B16C3F9B-61BD-4D89-8CFD-2321E9A73372Q35790574-A19E5DC7-D027-478F-BD15-9AC1E8A89D68Q36014649-2453E27B-2D68-4C4F-91E6-91B3F08CC984Q36041656-A136840B-2F76-44C6-B1C8-B031E78CE969Q36178536-ED6267BE-4966-449B-941D-E053AF2C09B4Q36179852-8012F592-EE82-4A28-B467-E9B1B2921DE2Q36385997-15A84B41-6C8C-47F5-942C-0147C4D4CC23Q36492336-90AD8F17-6CE9-45F5-96EF-B01DAADD8B64Q36506347-92930117-05E0-4D20-811B-28D0411AF734Q36570868-977A56D3-D81B-4948-AAB3-A60DC381DCF1Q36609438-9AC4AAAB-BC66-4D82-BB4D-7A416CB7D70CQ36776711-00FD41FC-E18E-46AC-A3AF-C88646F594BFQ36803517-4874521C-74B4-48F1-B7FF-A9682A360096Q37169303-E3A1E1C5-8337-4A4A-906C-8CD6083F0063Q37621036-A820C3EA-5083-4A65-92FD-845A48117B43Q37713780-910E07DB-B83D-4939-ADEB-C45C4E30CE45Q37809363-6CA3667F-5EF7-4D02-AF5D-D41355CD0ACDQ37883067-0F855433-3C90-4FCD-9364-AF6C512891E5
P2860
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Selective inhibition of cycloo ...... ophageal adenocarcinoma cells.
@en
type
label
Selective inhibition of cycloo ...... ophageal adenocarcinoma cells.
@en
prefLabel
Selective inhibition of cycloo ...... ophageal adenocarcinoma cells.
@en
P2093
P1433
P1476
Selective inhibition of cycloo ...... ophageal adenocarcinoma cells.
@en
P2093
P304
P407
P577
2000-10-01T00:00:00Z